Healthcare provider profile · identity verified

Andrew E. Oja, PA-C

Physician Assistant · LEWISTOWN, PA · NPI 1275596116

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	836	230
Omeprazole	Omeprazole	607	173
Levothyroxine Sodium	Levothyroxine Sodium	512	132
Lisinopril	Lisinopril	471	130
Gabapentin	Gabapentin	412	106
Albuterol Sulfate Hfa	Albuterol Sulfate	315	102
Rosuvastatin Calcium	Rosuvastatin Calcium	292	77
Metformin Hcl	Metformin Hcl	275	78
Pantoprazole Sodium	Pantoprazole Sodium	254	61
Hydrochlorothiazide	Hydrochlorothiazide	252	68
Metformin Hcl Er	Metformin Hcl	238	58
Losartan Potassium	Losartan Potassium	234	73
Amlodipine Besylate	Amlodipine Besylate	230	73
Tizanidine Hcl	Tizanidine Hcl	212	57
Metoprolol Succinate	Metoprolol Succinate	199	59
Jardiance	Empagliflozin	186	39
Furosemide	Furosemide	184	60
Ozempic	Semaglutide	184	33
Simvastatin	Simvastatin	184	50
Allopurinol	Allopurinol	183	47
Prednisone	Prednisone	182	99
Atenolol	Atenolol	177	48
Diclofenac Sodium	Diclofenac Sodium	170	45
Tramadol Hcl	Tramadol Hcl	163	40
Buspirone Hcl	Buspirone Hcl	158	34
Duloxetine Hcl	Duloxetine Hcl	158	35
Metoprolol Tartrate	Metoprolol Tartrate	153	44
Tamsulosin Hcl	Tamsulosin Hcl	153	42
Pregabalin	Pregabalin	151	37
Warfarin Sodium	Warfarin Sodium	149	46
Fluticasone Propionate	Fluticasone Propionate	146	56
Montelukast Sodium	Montelukast Sodium	145	41
Potassium Chloride	Potassium Chloride	145	34
Trazodone Hcl	Trazodone Hcl	142	33
Eliquis	Apixaban	141	33
Famotidine	Famotidine	141	35
Escitalopram Oxalate	Escitalopram Oxalate	126	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	115	30
Clopidogrel	Clopidogrel Bisulfate	111	31
Sertraline Hcl	Sertraline Hcl	109	30
Lorazepam	Lorazepam	107	16
Hydroxyzine Hcl	Hydroxyzine Hcl	106	30
Citalopram Hbr	Citalopram Hydrobromide	105	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	99	34
Meloxicam	Meloxicam	98	25
Alprazolam	Alprazolam	92	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	26
Venlafaxine Hcl Er	Venlafaxine Hcl	81	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	19
Pravastatin Sodium	Pravastatin Sodium	79	25
Azithromycin	Azithromycin	78	57
Ropinirole Hcl	Ropinirole Hcl	76	21
Glipizide Er	Glipizide	75	18
Carvedilol	Carvedilol	73	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	19
Bupropion Xl	Bupropion Hcl	67	11
Fluoxetine Hcl	Fluoxetine Hcl	66	18
Oxybutynin Chloride Er	Oxybutynin Chloride	63	15
Alendronate Sodium	Alendronate Sodium	62	14
Amoxicillin	Amoxicillin	62	50
Naproxen	Naproxen	60	13
Glimepiride	Glimepiride	58	14
Levetiracetam	Levetiracetam	58	11
Memantine Hcl	Memantine Hcl	57	suppressed
Ondansetron Hcl	Ondansetron Hcl	52	21
Primidone	Primidone	52	suppressed
Xarelto	Rivaroxaban	50	suppressed
Donepezil Hcl	Donepezil Hcl	49	13
Fenofibrate	Fenofibrate Nanocrystallized	49	11
Torsemide	Torsemide	49	17
Triamcinolone Acetonide	Triamcinolone Acetonide	49	28
Valacyclovir	Valacyclovir Hcl	48	15
Ibuprofen	Ibuprofen	46	19
Finasteride	Finasteride	45	11
Cephalexin	Cephalexin	44	34
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Baclofen	Baclofen	43	14
Doxycycline Hyclate	Doxycycline Hyclate	42	33
Lovastatin	Lovastatin	42	suppressed
Trulicity	Dulaglutide	42	11
Breo Ellipta	Fluticasone/Vilanterol	41	11
Tradjenta	Linagliptin	41	suppressed
Ezetimibe	Ezetimibe	40	14
Oxycodone Hcl	Oxycodone Hcl	40	13
Ventolin Hfa	Albuterol Sulfate	40	13
Benazepril Hcl	Benazepril Hcl	39	suppressed
Fluconazole	Fluconazole	38	20
Sucralfate	Sucralfate	38	suppressed
Topiramate	Topiramate	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Novolog Flexpen	Insulin Aspart	36	14
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Meclizine Hcl	Meclizine Hcl	34	18
Ondansetron Odt	Ondansetron	33	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	27
Carbamazepine	Carbamazepine	32	suppressed
Lamotrigine	Lamotrigine	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Nitroglycerin	Nitroglycerin	31	27
Clonazepam	Clonazepam	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Risperidone	Risperidone	25	suppressed
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Repaglinide	Repaglinide	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Clotrimazole	Clotrimazole	22	suppressed
Colchicine	Colchicine	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Unifine Pentips	Pen Needle, Diabetic	20	suppressed
Lactulose	Lactulose	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Clonidine Hcl	Clonidine Hcl	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Enulose	Lactulose	15	suppressed
Glipizide	Glipizide	15	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Nystatin	Nystatin	14	11
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Estradiol	Estradiol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Levocarnitine	Levocarnitine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Novolog	Insulin Aspart	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Digoxin	Digoxin	11	suppressed
Erythromycin-Benzoyl Peroxide	Erythromycin/Benzoyl Peroxide	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error